Tuberculosis is an infection caused by Mycobacterium tuberculosis that mainly affects the lungs. It can spread through droplets in the air from coughing or sneezing. Symptoms include persistent cough, chest pain, coughing up blood, fatigue, and fever. TB is classified as pulmonary or extra-pulmonary depending on the affected area. Diagnosis involves sputum tests, chest x-rays, and the tuberculin skin test. Treatment requires a multi-drug regimen over several months. Preventive measures include BCG vaccination, isolation, and proper ventilation. Drug-resistant forms like MDR-TB and XDR-TB are major challenges. Co-infection with HIV increases the risks of TB infection and
Intro to TB
epidemiology of TB
Structure of Mycobacterium TB
pathogenesis of TB
Immunosuppression by Mycobacterium TB
types of TB
Clinical manifestation
Diagnosis
Treatment
Intro to TB
epidemiology of TB
Structure of Mycobacterium TB
pathogenesis of TB
Immunosuppression by Mycobacterium TB
types of TB
Clinical manifestation
Diagnosis
Treatment
This is about tuberculosis , features, diagnosis and management. With reference to Uganda Clinical Guidelines
By Okeke Gloria, Kasule Steven, Sengooba Dennis Nyanzi
This ppt gives you idea about pathophysiology of tuberculosis and the pharmacology of drugs used to treat this infection. And it also give deep introduction of molecular interaction of mycobacteria with body i.e.. immune response by human to this mycobacteria.
it also gives you idea about treatment regimens and strategy for TB. discussed the different types of TB and mechanism of development of resistance by mycobacteria for anti-TB drugs.
This is about tuberculosis , features, diagnosis and management. With reference to Uganda Clinical Guidelines
By Okeke Gloria, Kasule Steven, Sengooba Dennis Nyanzi
This ppt gives you idea about pathophysiology of tuberculosis and the pharmacology of drugs used to treat this infection. And it also give deep introduction of molecular interaction of mycobacteria with body i.e.. immune response by human to this mycobacteria.
it also gives you idea about treatment regimens and strategy for TB. discussed the different types of TB and mechanism of development of resistance by mycobacteria for anti-TB drugs.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
tuberculosis-150808111627-lva1-app6891.pptx
1.
2. Definition
⚫Tuberculosis (TB) is a potentially fatal
contagious disease that can affect almost any part
of the body but is mainly an infection of the
lungs.
Neo-latin word :
- Round nodule/Swelling
- Condition
“Tubercle”
“Osis”
4. Other causative organisms
⚫Mycobacterium africanum
⚫Mycobacterium microti
Non-Mycobacterium Genus
⚫Mycobacterium leprae
⚫Mycobacterium avium
⚫Mycobacterium asiaticum
M.
africanum
M. Bovis
M. Canetti
M. microti
M. tuberculosis complex
6. Classification
Pulmonary TB
- Primary Disease
- Secondary Disease
Extra pulmonary
i. Lymph node TB
ii. Pleural TB
iii. TB of upper airways
iv. Skeletal TB
v. Genitourinary TB
vi. Miliary TB
vii. Pericardial TB
viii. Gastrointestinal TB
ix. Tuberculous Meningitis
x. Less common forms
12. Types
A. Pulmonary TB :-
1. Primary Tuberculosis :-
The infection of an individual who has not been previously
infected or immunised is called Primary tuberculosis or Ghon’s
complex or childhood tuberculosis.
Lesions forming after infection is peripheral and accompanied by
hilar which may not be detectable on chest radiography.
2. Secondary Tuberculosis :
The infection that individual who has been previously infected or
sensitized is called secondary or post primary or reinfection or chronic
tuberculosis.
13. B} Extra Pulmonary TB :-
20% of patients of TB Patient
Affected sites in body are :-
1) Lymph node TB ( tuberculuous lymphadenitis):-
Seen frequently in HIV infected patients.
Symptoms :- Painless swelling of lymph nodes most commonly at
cervical and Supraclavical (Scrofula)
Systemic systems are limited to HIV infected patients.
2) Pleural TB :-
Involvement of pleura is common in Primary TB
and results from penetration of tubercle bacilli into pleural
space.
14. 3) TB of Upper airways :-
Involvement of larynx, pharynx and epiglottis.
Symptoms :- Dysphagia, chronic productive cough
4) GenitourinaryTB :-
• 15% of all Extra pulmonary cases.
• Any part of the genitourinary tract get infected.
• Symptoms :- Urinary frequency, Dysuria, Hematuria.
5) Skeletal TB :-
• Involvement of weight bearing parts like spine, hip,
knee.
• Symptoms :- Pain in hip joints n knees, swelling of
knees, trauma.
6) Gastrointestinal TB :-
Involvement of any part of GI Tract.
Symptoms :- Abdominal pain, diarrhea, weight loss
15. 7) TB Meningitis & Tuberculoma :-
5% of All Extra pulmonary TB
Results from Hematogenousspead of 10 & 20 TB.
8) TB Pericardiatis :-
• 1- 8% of All Extra pulmonaryTB cases.
• Spreads mainly in mediastinal or hilar nodes
or from lungs.
9) Miliary ordisseminated TB :-
• Results from Hematogenous spread of Tubercle Bacilli.
•Spread isdue toentry of infection into pulmonaryvein
producing
lesions in different extrapulmonary sites.
10) Lesscommon Extra PulmonaryTB
uveitis, panophthalmitis, painfull Hypersensitivity
related phlyctenularconjuctivis.
17. 3.Radiography:
Chest X-Ray(CXR)
4.Nucleic acid amplification:
⚫ Species identification ; several hours
⚫ Low sensitivity, high cost
⚫ Most useful for the rapid confirmation of
tuberculosis in persons with AFB-positive sputa
⚫ Utility
⚫ AFB-negative pulmonary tuberculosis
⚫ Extra pulmonary tuberculosis
18. 5.Tuberculin skin test (PPD)
Injection of fluid into
the skin of the lower
arm.
48-72 hours later –
checked for a reaction.
Diagnosis is based on
the size of the wheal.
1 dose = 0.1 ml contains 0.04µg
Tuberculin PPD.
21. 6. Other biological examinations
Cell count(lymphocytes)
Protein(Pandyand Rivalta tests) – Ascites, pleural
effusion and meningitis.
22. Preventive measures
1) Mask
2) BCG vaccine
3) Regular medical follow up
4) Isolation of Patient
5) Ventilation
6) Natural sunlight
7) UV germicidal irradiation
23.
24. BCG vaccine
⚫ Bacille Calmette Guerin (BCG).
⚫ First used in 1921.
⚫ Onlyvaccine available today forprotectionagainst tuberculosis.
⚫ It is mosteffective in protecting children from thedisease.
⚫ Given 0.1 ml intradermally.
⚫ Durationof Protection 15 to 20 years
⚫ Efficacy 0 to 80%.
⚫ Should begiven toall healthy infantsas soonas possibleafterbirth
unless thechild presented with symptomatic HIV infection.
26. Drugs MOA Diagram
Isoniazid Inhibits mycolic acid synthesis.
RIFAMPICIN Blocks RNA synthesis by blocking
DNA dependent RNA polymerase
PYRAZINAMIDE •Bactericidal-slowly metabolizing
organism within acidic
environment of Phagocyte or
caseous granuloma.
27. Drugs MOA Diagram
ETHAMBUTOL •Bacteriostatic
•Inhibition of Arabinosyl
Transferase
STREPTOMYCIN •Inhibition of Protein
synthesis by disruption of
ribosomal function
30. Treatment regimen according to WHO
ISONIAZID (H) RIFAMPICIN (R) PYRAZINAMIDE (Z)
ETHAMBUTOL (E) STREPTOMYCIN (S)
31. DOTS
DOTS - Directlyobserved treatment, short-course
⚫ DOT means that a trained health care worker or other designated
individual provides the prescribed TB drugsand watches the patient
swalloweverydose.
32. Multi-Drug Resistance TB
TB caused by strains of Mycobacterium
tuberculosis that are resistant toat least isoniazid
and rifampicin, the mosteffectiveanti- TB drug.
Globally, 3.6% are estimated to have MDR-TB.
Almost 50% of MDR-TB cases worldwide are
estimated tooccur in China and India.
33. Extensively drug resistance TB
⚫Extensivelydrug-resistantTB (XDR-TB) is a form of TB
caused by bacteria that are resistant to isoniazid and
rifampicin (i.e. MDR-TB) as well as any fluoroquinolone
and any of the second-line anti-TB injectable drugs
(amikacin, kanamycin orcapreomycin).
34. Tuberculosis and HIV
⚫Worldwide the numberof people infected with both
HIV and TB is rising.
⚫The HIV virusdamages the body’s immunesystemand
accelerates the speed at which TB progresses from a
harmless infection toa life threatening condition.
⚫Theestimated 10% activationof dormantTB infection
overthe life span of an infected person, is increased to
10% activation in one year, if HIV infection is
superimposed.
⚫It is theopputunistic infection that most frequently
kills HIV-positive people.
35. Epidemiological Impact
⚫Reactivation of latent infection- People who are
infected with both HIV and TB are 25 to 30 times more
likely to develop TB again than people only infected
with TB.
⚫Primary Infection- New tubercular infection in
peoplewith HIV can progress toactivediseasevery
quickly.
⚫Recurring infection- in peoplewhowerecured of
TB.
36. Diagnosis of TB in people with HIV
⚫HIV positive people with pulmonary TB may have a
higher frequencyof having sputum negativesmears.
⚫The tuberculin test often fails to work, because the
immunesystem has been damaged by HIV; It may not
even showa responseeven though the person is
infected with TB.
⚫ChestXraywill show lesscavitation.
⚫Casesof Extra pulmonaryTB are morecommon.